Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
CHRS
Coherus Oncology Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Coherus Oncology Inc (CHRS) Earnings
Last reported
April 30, 2026
EPS estimate
-$0.28
EPS actual
—
Revenue est.
$14.6M
Revenue actual
—
Related:
CHRS overview
·
CHRS financials
·
CHRS news